Cargando…
Development of Meloxicam-Human Serum Albumin Nanoparticles for Nose-to-Brain Delivery via Application of a Quality by Design Approach
The aim of this study was to optimize the formulation of meloxicam (MEL)-containing human serum albumin (HSA) nanoparticles for nose-to-brain via a quality by design (QbD) approach. Liquid and dried formulations of nanoparticles containing Tween 80 and without the surfactant were investigated. Vario...
Autores principales: | Katona, Gábor, Balogh, György Tibor, Dargó, Gergő, Gáspár, Róbert, Márki, Árpád, Ducza, Eszter, Sztojkov-Ivanov, Anita, Tömösi, Ferenc, Kecskeméti, Gábor, Janáky, Tamás, Kiss, Tamás, Ambrus, Rita, Pallagi, Edina, Szabó-Révész, Piroska, Csóka, Ildikó |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076499/ https://www.ncbi.nlm.nih.gov/pubmed/31991767 http://dx.doi.org/10.3390/pharmaceutics12020097 |
Ejemplares similares
-
Investigation of Absorption Routes of Meloxicam and Its Salt Form from Intranasal Delivery Systems
por: Bartos, Csilla, et al.
Publicado: (2018) -
Transformation of Meloxicam Containing Nanosuspension into Surfactant-Free Solid Compositions to Increase the Product Stability and Drug Bioavailability for Rapid Analgesia
por: Bartos, Csaba, et al.
Publicado: (2019) -
Investigation of the Absorption of Nanosized lamotrigine Containing Nasal Powder via the Nasal Cavity
por: Ambrus, Rita, et al.
Publicado: (2020) -
Quality by Design Based Formulation Study of Meloxicam-Loaded Polymeric Micelles for Intranasal Administration
por: Sipos, Bence, et al.
Publicado: (2020) -
Preliminary study of nanonized lamotrigine containing products for nasal powder formulation
por: Gieszinger, Péter, et al.
Publicado: (2017)